Video Experimental Relacionado
Updated: Sep 10, 2025
09:15
Induction of Eryptosis in Red Blood Cells Using a Calcium Ionophore
Published on: January 21, 2020
8.9K
Eryptosis en enfermedades del hígado: contribución a la anemia y la hipercoagulación
Saulesh Kurmangaliyeva1, Kristina Baktikulova1, Anton Tkachenko2
1Department of Microbiology, Virology, and Immunology, NJSC "West Kazakhstan Marat Ospanov Medical University", 68 Maresyev st, Aktobe 030000, Kazakhstan.
Medical sciences (Basel, Switzerland)
|August 22, 2025
Resumen
La eritrosis acelerada, una forma de muerte programada de los glóbulos rojos, contribuye a la anemia y la hipercoagulación en las enfermedades hepáticas. El tratamiento de la eritosis puede ofrecer estrategias terapéuticas para estas afecciones.
Área de la Ciencia:
- Biología celular
- Hematología
- Hepatología
Sus antecedentes:
- La eritrosis, una muerte celular regulada de los eritrocitos, implica la afluencia de Ca2+ y la externalización de fosfatidilserina.
- La eritrosis acelerada está relacionada con varias enfermedades, especialmente la anemia, y está cada vez más implicada en la patología hepática.
- Comprender la eritosis es crucial para comprender la anemia y la hipercoagulación en la patogénesis de la enfermedad hepática.
Objetivo del estudio:
- Revisar las vías de señalización y las funciones fisiológicas de la eritosis.
- Analizar exhaustivamente el impacto de la eritosis en las enfermedades hepáticas y las complicaciones asociadas.
- Explorar estrategias terapéuticas potenciales dirigidas a la eritosis en la enfermedad hepática.
Principales métodos:
- Análisis sistemático de las publicaciones indexadas en PubMed sobre eritosis y enfermedades hepáticas.
- Revisión de los conocimientos actuales sobre la señalización de la eritosis, las funciones fisiológicas y las asociaciones de enfermedades.
- Examen de metabolitos y medicamentos que pueden inducir la eritosis en la enfermedad hepática.
Principales resultados:
- La eritosis contribuye a la anemia, la hipercoagulación y el daño endotelial en las enfermedades hepáticas.
- Los metabolitos específicos (bilirrubina, ácidos biliares) y los fármacos pueden desencadenar eritosis en las afecciones hepáticas.
- La eritosis inducida por fármacos puede explicar en parte la anemia asociada al tratamiento en pacientes con enfermedad hepática.
Conclusiones:
- La eritosis juega un papel importante en la patogénesis y las complicaciones de las enfermedades hepáticas.
- La inhibición de la eritrosis presenta una vía terapéutica potencial para el tratamiento de la anemia y la trombosis en la enfermedad hepática.
- La investigación adicional sobre la modulación de la eritosis podría conducir a nuevos tratamientos para las patologías hepáticas.
Videos de Conceptos Relacionados
01:27Disorders of Erythrocytes
1.2K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
1.2K
01:22Lifecycle of Erythrocytes
2.3K
Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
2.3K
01:24Factors Affecting Erythropoiesis
3.6K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.6K
01:14Erythropoiesis
4.7K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.7K
01:24Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
01:01Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K